In This Round, Humans 1, AI LLMs 0

The latest stories trending on MedCity News.

Editor's Pick

Top Story In This Round, Humans 1, AI LLMs 0 Anthropic's Claude3-Opus performed better than GPT-4, but both fell short of humans on a test of objective medical knowledge. The study was conducted by a firm developing LLMs specifically for healthcare that claim to be incorporating peer-reviewed sources of information. Sponsored Save 30% and the HLTH 2024 Preliminary Agenda Revealed! Presented by HLTH Whether you're into cutting-edge health tech, passionate about policy shifts in healthcare, or just love a good debate on digital health, the HLTH 2024 agenda has got you covered. View the Preliminary Agenda Meet MedCity News in Dallas for INVEST Digital Health Conference on September 18 This year's conference at Pegasus Park, Dallas promises to be our most dynamic yet, bringing together visionaries, investors, and industry leaders.  See Conference Agenda here: Agenda - MedCity INVEST (medcityinvestconference.com) Whether you're a startup entrepreneur, investor, healthcare professional, or simply passionate about transforming the industry, INVEST Digital Health on September 18 is your platform to connect and learn. Register Today

Featured News

Vitable Secures $16M To Provide Primary Care to Small Employers Vitable's $16 million Series A funding round was led by Cherryrock Capital and included participation from newark venture partners, Citi Impact Fund, First Round Capital, Commerce Ventures and Y Combinator. In total, Vitable has raised more than $25 million. Neuro Drug Passed Up by Biogen Posts Positive Data for Ionis, Setting Stage for Phase 3 Test Ionis Pharmaceuticals is looking ahead to a Phase 3 study for an antisense medicine it is developing to treat Angelman syndrome, a rare neurodevelopmental disorder with no FDA-approved therapies. Its main competition is an Ultragenyx Pharmaceutical drug set to begin pivotal testing later this year. The Future of Birth Control: No Hormones, More Options for Men The advancement, adoption of, and access to these options – regardless of age, geography, and financial considerations – requires the support of the scientific community, drug developers, funders, regulatory agencies, insurers, and lawmakers to make the concept of a hormone-free future a reality. Home Dialysis Advances Will Make Transplant Wait a Little Easier For folks on the transplant waiting list, the wait from now on should be less disruptive. Life should be more pleasant. And all things being equal, one's condition going into a transplant should be better. Implementing Inclusivity: Putting Clinical Trial Equity Into Practice In the realm of inclusivity and equity, planning early and engaging key stakeholders throughout the process makes it possible to make these changes while also safeguarding participants. How can researchers put clinical trial equity into practice?

Resources

AI in Healthcare: The Next Chapter The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe